HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

7th Edition of Global Conference on Surgery and Anaesthesia

September 24-26, 2026 | Hybrid Event

September 24 -26, 2026 | London, UK
GCSA 2026

Renal autotransplantation for a hypervascular renal tumour in a solitary kidney: Ex vivo bench surgery to preserve renal function

Christos Costa, Speaker at Surgery Conference
Oxford University Hospitals NHS Foundation Trust, United Kingdom
Title : Renal autotransplantation for a hypervascular renal tumour in a solitary kidney: Ex vivo bench surgery to preserve renal function

Abstract:

Introduction: Managing complex renal tumours in a solitary functioning kidney represents a major surgical challenge, where oncological control must be balanced against avoidance of dialysis. In highly vascular or centrally located tumours, conventional nephron-sparing surgery may be unsafe due to haemorrhage risk and prolonged warm ischaemia. Ex vivo bench tumour excision with renal autotransplantation offers a nephron-preserving alternative in selected cases but is rarely performed outside specialist centres.

Case Presentation: A man in his mid-sixties with a solitary left kidney following prior donation presented with visible haematuria and urinary retention. Imaging demonstrated a hypervascular lower-pole renal mass with arteriovenous shunting and hydronephrosis. Repeated embolisation failed to fully devascularise the lesion, and biopsy was limited by bleeding risk. Multidisciplinary review concluded that in-situ partial nephrectomy carried unacceptable risk of catastrophic haemorrhage and renal failure, while radical nephrectomy would result in dialysis dependence. The patient therefore underwent laparoscopic nephrectomy, ex vivo bench tumour excision under cold ischaemia, and renal autotransplantation into the right iliac fossa.

Results: Surgery was technically demanding due to prior embolisation, dense fibrosis and distorted hilar anatomy. Warm ischaemia time was approximately five minutes and cold ischaemia just under six hours. Immediate graft reperfusion and urine production were achieved. Postoperative complications included pulmonary embolism, infected urinoma requiring drainage, and urinary tract infection, all managed successfully without graft loss. Renal function stabilised at creatinine ~150 µmol/L (eGFR 40–45 mL/min/1.73 m²), avoiding dialysis. At 20-month follow-up, imaging demonstrated no recurrence and preserved graft function.

Conclusion: Ex vivo bench surgery with renal autotransplantation can provide definitive oncological management while preserving renal function in carefully selected patients with solitary kidneys. Although associated with significant morbidity, this approach remains a valuable nephron-preserving strategy when conventional surgery is not feasible.

Biography:

Christos Costa MBBS, MSc, MRCS is a surgical trainee at Oxford University Hospitals NHS Foundation Trust. He completed a Specialised Foundation Programme in cardiothoracic surgery at Imperial College Healthcare NHS Trust and graduated from Barts and The London School of Medicine and Dentistry with triple distinction. His academic interests include surgical innovation, clinical outcomes research, and medical education. He has published multiple papers in high-impact peer-reviewed journals and has presented work at national and international conferences. Alongside clinical training, he remains actively involved in teaching, mentorship, and collaborative research aimed at advancing evidence-based surgical practice and improving patient outcomes.

Watsapp